Effect of High Intensity Aerobic Exercise on Pain Threshold and Blood Pressure in Females With Primary Dysmenorrhea
1 other identifier
interventional
110
1 country
1
Brief Summary
Primary dysmenorrhea is common among females of reproductive age and is characterized by painful menstrual cramps without an underlying pelvic disease. This pain can affect daily activities, academic performance, work, and quality of life. This study aims to investigate the effect of high-intensity aerobic exercise on pain threshold and blood pressure in females with primary dysmenorrhea. The study will assess changes in pain threshold and blood pressure following high-intensity aerobic exercise. The findings may help determine whether this type of exercise can improve pain tolerance and influence blood pressure in females experiencing painful menstrual periods. Participants will perform a high-intensity aerobic exercise program, and their pain threshold level will be assessed by a digital algometer before and after the exercise intervention and the blood pressure changes will also be studied.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 4, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 4, 2026
CompletedFirst Submitted
Initial submission to the registry
October 6, 2026
CompletedFirst Posted
Study publicly available on registry
October 23, 2026
CompletedOctober 23, 2026
October 1, 2026
12 months
October 6, 2026
October 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Pain Threshold
Pain Threshold: Measured using a digital algometer at four muscle sites: trapezius (5 cm from the acromion), biceps (15 cm from the glenoid cavity or 9 cm above the elbow crease), rectus abdominis (4 cm lateral to the umbilicus), and gastrocnemius (midpoint between the popliteal fossa and heel). The 1 cm² probe is pressed vertically at 30 kPa until pain is reported; the device automatically records the threshold in kilograms.
Pretest (menstrual days 1-4), post-test 1 (week 4), and post-test 2 (week 8), during menstrual days 1-4.
Blood Pressure
It is measured using Omron Digital blood pressure monitor. Both Systolic and Diastolic blood pressure will be measured.
On Pretest- all days of menses (day1-day4) .For Post test 1 (at end of 4th week) , Post test 2(at end of 8th week) during day1-day 4 of menses. Recorded in the left arm three times and average is noted. Measured for experimental and control group.
Study Arms (2)
Experimental Group- 55 participants
EXPERIMENTALHigh Intensity Aerobic Exercise given at 85 % of heart rate. 3 times/week /25 minute per session with 5 minutes warm up and 5 minutes cool down.
Control group-55 participants
NO INTERVENTIONNo treatment given.Participants instructed to carry on with usual lifestyle and do not begin any new exercise program
Interventions
intervention intensity is high and consist of structured exercise program
Eligibility Criteria
You may qualify if:
- Females Age 17-49 years
- History of PD for past 3 months with months (Visual Analogue pain scale more than 5 on day 1 and 2 and consecutive days)
- Unmarried
- Nulliparous
- Normal menstrual cycle - 28-35 days cycle
- Body mass Index Normal to overweight(18.5-25 kg/m2 is normal)
You may not qualify if:
- Any secondary dysmenorrhea or Gynecologic issue
- Active in sports
- Any Cardiorespiratory or musculoskeletal issue
- History of Hypertension
- Oral contraceptives or Analgesic
- Participants need to undergo Primary Dysmenorrhea Screening conducted by a Gynecologist to get diagnosed with Primary Dysmenorrhea and be further eligible to be a part of the further study.
- This consist of detailed menstrual history taking and abdominal and pelvis palpation by the Gynecologist doctor.
- A general health check-up was also included to rule out any hypertension issue.
- Some important points were considered as well :
- VAS score: Visual analogue scale VAS score greater than 5 is required on both the first and second days of menstruation
- Medication use: Define the required medication-free period, if any, and whether occasional analgesic use is permitted.
- Participants should not be instructed to discontinue prescribed medication without appropriate clinical guidance.
- Blood pressure safety: Since intervention involves high-intensity aerobic exercise and blood pressure is an outcome, include a suitable pre-exercise screening procedure and safety criteria for elevated blood pressure. Blood pressure was measured in this session as well along with BMI.
- Medication use: Define the required medication-free period, if any, and whether occasional analgesic use is permitted.
- Participants should not be instructed to discontinue prescribed medication without appropriate clinical guidance.
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lincoln University Collegelead
- Lincoln University College Malaysiacollaborator
- Universiti Tunku Abdul Rahmancollaborator
Study Sites (1)
Physiotherapy department UTAR sungai Long
Cheras, Selangor, 43000, Malaysia
Study Officials
- STUDY DIRECTOR
Nisha Nambiar, PhD
Lincoln University College
- STUDY CHAIR
Faridah Mohd Said, PhD
Lincoln University College
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Scholar PhD in Health Science
Study Record Dates
First Submitted
October 6, 2026
First Posted
October 23, 2026
Study Start
September 5, 2024
Primary Completion
September 4, 2025
Study Completion
March 4, 2026
Last Updated
October 23, 2026
Record last verified: 2026-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- 5th September 2024- 4th Feb 2026
- Access Criteria
- Principal investigator,supervisor, co- supervisor, statistician and if needed publishing study
pain scores, blood pressure levels